[go: up one dir, main page]

ATE114118T1 - System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren. - Google Patents

System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren.

Info

Publication number
ATE114118T1
ATE114118T1 AT91911198T AT91911198T ATE114118T1 AT E114118 T1 ATE114118 T1 AT E114118T1 AT 91911198 T AT91911198 T AT 91911198T AT 91911198 T AT91911198 T AT 91911198T AT E114118 T1 ATE114118 T1 AT E114118T1
Authority
AT
Austria
Prior art keywords
level
current
iontophoretic
agent
drug delivery
Prior art date
Application number
AT91911198T
Other languages
English (en)
Inventor
Paul D Sorenson
John D Bradzinski
Gary A Lattin
Larry A Mcnichols
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27054046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE114118(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE114118T1 publication Critical patent/ATE114118T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT91911198T 1990-03-30 1991-03-22 System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren. ATE114118T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50217690A 1990-03-30 1990-03-30
US07/671,306 US5207752A (en) 1990-03-30 1991-03-21 Iontophoretic drug delivery system with two-stage delivery profile

Publications (1)

Publication Number Publication Date
ATE114118T1 true ATE114118T1 (de) 1994-12-15

Family

ID=27054046

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91911198T ATE114118T1 (de) 1990-03-30 1991-03-22 System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren.

Country Status (14)

Country Link
US (1) US5207752A (de)
EP (1) EP0522092B1 (de)
JP (1) JP3181289B2 (de)
KR (1) KR0169084B1 (de)
AT (1) ATE114118T1 (de)
AU (1) AU638581B2 (de)
CA (1) CA2079316C (de)
DE (1) DE69105202T2 (de)
DK (1) DK0522092T3 (de)
ES (1) ES2067939T3 (de)
FI (1) FI110066B (de)
GR (1) GR3015116T3 (de)
NO (1) NO308025B1 (de)
WO (1) WO1991015258A1 (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121372C (en) * 1991-12-03 2003-02-04 Ronald P. Haak Iontophoretic delivery device and power supply therefor
US5505715A (en) * 1994-02-25 1996-04-09 Bristol-Myers Squibb Company Iontophoretic transdermal delivery of deoxyspergualin compounds
US7027859B1 (en) 1994-09-26 2006-04-11 Alza Corporation Electrotransport delivery device having improved safety and reduced abuse potential
US5697896A (en) * 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
US5700481A (en) * 1995-03-17 1997-12-23 Takeda Chemical Industries, Ltd. Transdermal drug delivery process
EP0819016A1 (de) * 1995-04-07 1998-01-21 Novartis AG Iontophoretisches transdermales system zum verabreichen von mindestens zwei substanzen
IE960312A1 (en) * 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
AU710793B2 (en) * 1995-06-07 1999-09-30 Alza Corporation Electrotransport agent delivery method and apparatus
WO1997014473A1 (en) * 1995-10-18 1997-04-24 Novartis Ag Thermopile powered transdermal drug delivery device
US6718201B1 (en) * 1996-06-07 2004-04-06 Alza Corporation Electrotransport agent delivery method and apparatus
US5961483A (en) * 1996-06-19 1999-10-05 Sage; Burton H. Iontophoretic delivery of cell adhesion inhibitors
US5857994A (en) * 1996-10-01 1999-01-12 Becton, Dickinson And Company Awakenable iontophoretic/delivery device for reducing electrical sensation upon application thereof
FR2766093B1 (fr) * 1997-07-15 1999-09-03 Lhd Lab Hygiene Dietetique Procede de commande d'un dispositif d'administration transdermique de medicament sous champ electrique
KR20010033208A (ko) 1997-12-16 2001-04-25 스톤 스티븐 에프. 조정된 이송을 유지하기위해 인공 부하를 갖는 조정기
ES2281940T3 (es) 1997-12-17 2007-10-01 Alza Corporation Iontoforesis con ajuste programado de la corriente electrica.
HU222513B1 (hu) 1998-01-30 2003-08-28 Novo Nordisk A/S Injekciós fecskendő
WO2000047274A1 (en) 1999-02-10 2000-08-17 Gmp Drug Delivery, Inc. Iontophoresis, electroporation and combination patches for local drug delivery
US6471675B1 (en) 1999-04-30 2002-10-29 Medtronic, Inc. Passive flow control devices for implantable pumps
TW453884B (en) 1999-09-16 2001-09-11 Novo Nordisk As Dose setting limiter
US6663602B2 (en) 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
WO2002036072A2 (en) * 2000-11-03 2002-05-10 Biomedicines, Inc. Method for short-term and long-term drug dosimetry
ATE481135T1 (de) * 2001-11-09 2010-10-15 Intarcia Therapeutics Inc Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
GB0304822D0 (en) * 2003-03-03 2003-04-09 Dca Internat Ltd Improvements in and relating to a pen-type injector
EP2210634A1 (de) * 2009-01-22 2010-07-28 Sanofi-Aventis Deutschland GmbH Dosierungseinstellungsmechanismus für Arzneimittelabgabevorrichtung
GB0308267D0 (en) * 2003-04-10 2003-05-14 Dca Design Int Ltd Improvements in and relating to a pen-type injector
US7220778B2 (en) * 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
US7596407B2 (en) * 2004-03-26 2009-09-29 Solvay Pharmaceuticals, B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
EP1595542A1 (de) * 2004-03-26 2005-11-16 Solvay Pharmaceuticals B.V. Transdermale iontophoretische Verabreichung von Piperazinyl-2(3H)-benzoxazolon-Verbindungen
DE602005016952D1 (de) 2004-10-21 2009-11-12 Novo Nordisk As Wählmechanismus für einen drehstift
US8052996B2 (en) 2005-02-03 2011-11-08 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US20080208142A1 (en) * 2005-02-28 2008-08-28 Novo Nordisk A/S Dose Setting Mechanism for an Injection Device
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
JP4979686B2 (ja) 2005-04-24 2012-07-18 ノボ・ノルデイスク・エー／エス 注入デバイス
US20070093788A1 (en) * 2005-09-30 2007-04-26 Darrick Carter Iontophoresis method and apparatus for systemic delivery of active agents
WO2007046103A2 (en) * 2005-10-19 2007-04-26 Perf-Action Technologies Ltd. System for iontophoretic transdermal delivery of polymeric agents and methods of use thereof
EP1996259B1 (de) 2006-03-10 2012-08-15 Novo Nordisk A/S Injiziervorrichtung und verfahren zum wechseln einer patrone in der vorrichtung
CN101400394B (zh) 2006-03-10 2012-07-04 诺沃-诺迪斯克有限公司 具有传动部件的注射装置
JP5580042B2 (ja) * 2006-04-13 2014-08-27 ヌパス インコーポレイテッド 抗片頭痛化合物の送達のための経皮的方法およびシステム
AU2012261753B2 (en) * 2006-04-13 2015-03-05 Teva Pharmaceuticals International Gmbh Transdermal methods and systems for the delivery of anti-migraine compounds
WO2007132526A1 (ja) * 2006-05-16 2007-11-22 Rorze Corporation シャトル型搬送装置、マイクロプレート供給回収装置、マイクロプレート用ピックアップ装置、マイクロプレート用カセット、及びマイクロプレート用収納棚
US8226618B2 (en) * 2006-05-16 2012-07-24 Novo Nordisk A/S Gearing mechanism for an injection device
EP2374488B1 (de) 2006-05-18 2018-03-21 Novo Nordisk A/S Injektionsvorrichtung mit Modussperrmöglichkeiten
PT2359808E (pt) 2006-08-09 2013-08-28 Intarcia Therapeutics Inc Sistemas de entrega osmótica e montagens de pistão
US8728059B2 (en) * 2006-09-29 2014-05-20 Covidien Lp System and method for assuring validity of monitoring parameter in combination with a therapeutic device
EP2109474B2 (de) 2007-02-05 2019-01-30 Novo Nordisk A/S Injektionsknopf
US8353878B2 (en) 2007-03-23 2013-01-15 Novo Nordisk A/S Injection device comprising a locking nut
PL2157967T3 (pl) 2007-04-23 2013-06-28 Intarcia Therapeutics Inc Formulacje zawiesinowe peptydów insulinotropowych i ich zastosowania
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
CA2724949A1 (en) * 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodynamic therapy
US20090043244A1 (en) * 2007-08-08 2009-02-12 Inan Omer T Electrotransport Drug Delivery Device Adaptable to Skin Resistance Change
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US20090259176A1 (en) * 2008-04-09 2009-10-15 Los Gatos Research, Inc. Transdermal patch system
US20090312689A1 (en) * 2008-06-05 2009-12-17 Alza Corporation Adjustable Current Electrotransport Fentanyl Delivery Device
US8366600B2 (en) * 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
US8155737B2 (en) * 2008-06-19 2012-04-10 Nupathe, Inc. Pharmacokinetics of iontophoretic sumatriptan administration
NZ622157A (en) * 2008-12-30 2015-10-30 Teva Pharmaceuticals Int Gmbh Electronic control of drug delivery system
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US9008765B2 (en) 2009-02-12 2015-04-14 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8903485B2 (en) 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
JP6116246B2 (ja) 2009-08-10 2017-04-19 テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー イオントフォレシスにより悪心および片頭痛を治療するための方法
HUE035862T2 (en) 2009-09-28 2018-05-28 Intarcia Therapeutics Inc Rapid establishment and/or termination of substantial steady-state drug delivery
WO2011046927A1 (en) * 2009-10-13 2011-04-21 Nupathe,Inc. Transdermal methods and systems for the delivery of rizatriptan
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
US8986279B2 (en) 2010-02-10 2015-03-24 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN106955415B (zh) 2011-03-24 2019-06-18 因卡伯实验室有限责任公司 用于治疗剂的两阶段经皮离子电渗递送的系统及方法
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
US8428708B1 (en) * 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
MX2014007375A (es) 2011-12-29 2014-08-22 Novo Nordisk As Jeringa autoinyectora de cuerda basada en resorte de torsion con mecanismo dosificador giratorio de aumento/disminucion.
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MX2017015504A (es) 2015-06-03 2018-05-15 Intarcia Therapeutics Inc Sistemas de colocacion y remoción de implante.
CA3024479A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
CN118903385A (zh) 2017-08-24 2024-11-08 诺和诺德股份有限公司 Glp-1组合物及其用途
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
PE20230819A1 (es) 2020-02-18 2023-05-19 Novo Nordisk As Composiciones y usos de glp-1

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3163166A (en) * 1961-04-28 1964-12-29 Colgate Palmolive Co Iontophoresis apparatus
US3618601A (en) * 1969-10-16 1971-11-09 Thatcher W Richardson Iontophoresis unit
US3677268A (en) * 1969-11-28 1972-07-18 Sherwood Medical Ind Inc Iontophoresis electrode
US3794910A (en) * 1971-07-26 1974-02-26 Sherwood Medical Ind Inc Iontophoresis and conductivity analysis circuit
DE2339648C3 (de) * 1973-08-04 1979-09-13 Trebbin, Peter, 8833 Eichstaett Anästhesiegerät zur Behandlung der Zähne
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4211222A (en) * 1976-08-25 1980-07-08 Robert Tapper Iontophoretic burn-protection method
JPS5347192A (en) * 1976-10-13 1978-04-27 Matsushita Electric Ind Co Ltd Device for introducing fluorine ion to tooth
US4325367A (en) * 1977-06-13 1982-04-20 Robert Tapper Iontophoretic treatment apparatus
US4177817A (en) * 1978-02-01 1979-12-11 C. R. Bard, Inc. Dual terminal transcutaneous electrode
US4215696A (en) * 1978-03-20 1980-08-05 Graphic Controls Corporation Biomedical electrode with pressurized skin contact
US4209020A (en) * 1978-09-19 1980-06-24 Nielsen R Frederick Electrode assembly
US4301794A (en) * 1978-10-18 1981-11-24 Robert Tapper Method for iontophoretic treatment
US4340047A (en) * 1978-10-18 1982-07-20 Robert Tapper Iontophoretic treatment apparatus
US4292968A (en) * 1979-11-26 1981-10-06 Sybron Corporation Electric supply for ion therapy
AU546785B2 (en) * 1980-07-23 1985-09-19 Commonwealth Of Australia, The Open-loop controlled infusion of diabetics
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4450844A (en) * 1981-11-23 1984-05-29 Hill Top Research, Inc. Patch system for use on the skin
AU577731B2 (en) * 1983-04-15 1988-09-29 Jack Kenneth Ibbott Therapeutic method and appliance employing flat battery
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4731926A (en) * 1985-02-19 1988-03-22 Drug Delivery Systems Inc. Method of manufacturing disposable and/or replenishable transdermal drug applicators
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
US4883457A (en) * 1983-08-18 1989-11-28 Drug Delivery Systems Inc. Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4808152A (en) * 1983-08-18 1989-02-28 Drug Delivery Systems Inc. System and method for controlling rate of electrokinetic delivery of a drug
US4851229A (en) * 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
MX168630B (es) * 1985-06-10 1993-06-02 Drug Delivery Systems Inc Sistema y metodo para controlar la tasa de liberacion electrocinetica de un medicamento
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4725263A (en) * 1986-07-31 1988-02-16 Medtronic, Inc. Programmable constant current source transdermal drug delivery system
US4822334A (en) * 1986-12-04 1989-04-18 Robert Tapper Electrical dosimetry control system
US4731049A (en) * 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
JPH02500339A (ja) * 1987-05-15 1990-02-08 ニューマン，マーティン・エッチ イオン浸透薬剤供給装置
US4865582A (en) * 1987-06-05 1989-09-12 Drug Delivery Systems Inc. Disposable transdermal drug applicators

Also Published As

Publication number Publication date
FI110066B (fi) 2002-11-29
FI924352L (fi) 1992-09-28
US5207752A (en) 1993-05-04
DK0522092T3 (da) 1995-03-13
WO1991015258A1 (en) 1991-10-17
EP0522092B1 (de) 1994-11-17
CA2079316C (en) 2002-01-01
NO308025B1 (no) 2000-07-10
AU7991591A (en) 1991-10-30
JPH05505964A (ja) 1993-09-02
JP3181289B2 (ja) 2001-07-03
GR3015116T3 (en) 1995-05-31
NO923769L (no) 1992-11-30
NO923769D0 (no) 1992-09-28
EP0522092A1 (de) 1993-01-13
KR0169084B1 (ko) 1999-01-15
CA2079316A1 (en) 1991-10-01
DE69105202T2 (de) 1995-03-23
DE69105202D1 (de) 1994-12-22
KR930700181A (ko) 1993-03-13
AU638581B2 (en) 1993-07-01
FI924352A0 (fi) 1992-09-28
ES2067939T3 (es) 1995-04-01

Similar Documents

Publication Publication Date Title
ATE114118T1 (de) System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren.
ATE185083T1 (de) Vorrichtung zur verabreichung von medikamenten und genen durch elektroporation
ATE219373T1 (de) Medikamente zur behandlung von autoimmunerkrankungen mit interferon-tau
ATE170769T1 (de) Vorrichtung zur verabreichung von medikamenten durch elektrotransport
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DK85786D0 (da) Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf
ES2012944A6 (es) Procedimiento y su dispositivo para la admionistracion de farmacos mediante ionoforesis, para tratamiento loco-regionales.
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
KR870700373A (ko) 동전학적 의약투여 속도를 제어하는 시스텝 및 방법
ATE226094T1 (de) Verfahren zur arzneistoffabgabe mittels gentherapie
ES2043744T3 (es) Sistema de suministro transdermico de procaterol.
AR003979A1 (es) Administracion transdermica de vorozol.
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
RU97121729A (ru) Способ стимуляции репаративного остеогенеза
SE9101341D0 (sv) New medicinal use
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
RU97101420A (ru) Способ лечения тонзиллита
AU6102801A (en) Method of preventing or treating diabetes
RU94013606A (ru) Гемостимулятор
RU96117545A (ru) Способ лечения диабетической ретинопатии
UA30956A (uk) Спосіб лікування алергічного риніту
RU96102903A (ru) Способ стимуляции овуляции у больных с олигоменореей и хроническим рецидивирующим сальпингоофоритом

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked